These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 7041522)

  • 1. 1,25(OH)2D3 and renal function. A controlled clinical study in normal elderly women.
    Jensen GF; Christiansen C; Transbøl I
    Acta Med Scand; 1982; 211(1-2):51-4. PubMed ID: 7041522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
    Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A
    Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with vitamin 24,25 (OH)2D3 does not change serum levels of 1,25 (OH)2D or urinary calcium excretion rate in man.
    Thomsen K; Riis BJ; Hummer L; Christiansen C
    Acta Vitaminol Enzymol; 1985; 7(3-4):167-71. PubMed ID: 3879105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effect of 1,25-dihydroxyvitamin D3, prednisone, and 1,25-dihydroxyvitamin D3 plus prednisone on serum osteocalcin in normal individuals.
    Nielsen HK; Brixen K; Kassem M; Mosekilde L
    J Bone Miner Res; 1991 May; 6(5):435-41. PubMed ID: 2068950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
    Lambrinoudaki I; Chan DT; Lau CS; Wong RW; Yeung SS; Kung AW
    J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study.
    Brazier M; Grados F; Kamel S; Mathieu M; Morel A; Maamer M; Sebert JL; Fardellone P
    Clin Ther; 2005 Dec; 27(12):1885-93. PubMed ID: 16507374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early therapy of renal bone disease with calcitriol: a prospective double-blind study.
    Baker LR; Abrams SM; Roe CJ; Faugere MC; Fanti P; Subayti Y; Malluche HH
    Kidney Int Suppl; 1989 Nov; 27():S140-2. PubMed ID: 2699994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF; Christiansen C; Transbøl I
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered phosphorylation of a 91-kDa protein in particulate fractions of rat kidney after protracted 1,25-dihydroxyvitamin D3 or estrogen treatment.
    Qin X; Siaw EK; Cheung A; Walters MR
    Arch Biochem Biophys; 1997 Dec; 348(2):239-46. PubMed ID: 9434734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.
    Jensen GF; Meinecke B; Boesen J; Transbøl I
    Clin Orthop Relat Res; 1985; (192):215-21. PubMed ID: 3881203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
    Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of 1,25(OH)2D3 on bone mineral content in senile osteoporosis--a dose-finding study].
    Shiraki M; Ito H; Orimo H
    Nihon Naibunpi Gakkai Zasshi; 1989 Nov; 65(11):1253-63. PubMed ID: 2591609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic effect of 1,24(R)(OH)2D3 versus 1,25(OH)2D3 administration in chronic renal failure.
    Coen G; Bondatti F; Donato G; Mazzaferro S; Pasquali M; Rosini S; Sardella D; Taggi F
    J Steroid Biochem Mol Biol; 1992 Sep; 42(8):823-9. PubMed ID: 1525043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
    Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
    Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial.
    Baker LR; Abrams L; Roe CJ; Faugere MC; Fanti P; Subayti Y; Malluche HH
    Kidney Int; 1989 Feb; 35(2):661-9. PubMed ID: 2651758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
    Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
    Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.